| 產(chǎn)品編號 | bs-0114M-FITC |
| 英文名稱1 | Mouse Anti-Aromatase/FITC Conjugated antibody |
| 中文名稱 | FITC標記的芳香化酶抗體 |
| 別 名 | Cytochrome p450 19A1; Estrogen synthetase; ARO 1; ARO; ARO1; CPV; CYPXIX; Cytochrome P450 19A1; Cytochrome P450 family 19 subfamily A polypeptide 1; MGC104309; P 450AROM; P450AROM; CP19A_HUMAN; Cytochrome P-450AROM. |
| 規(guī)格價格 | 100ul/2980元 購買 大包裝/詢價 |
| 說 明 書 | 100ul |
| 研究領(lǐng)域 | 細胞生物 神經(jīng)生物學(xué) 信號轉(zhuǎn)導(dǎo) 激酶和磷酸酶 合成與降解 |
| 抗體來源 | Mouse |
| 克隆類型 | Polyclonal |
| 交叉反應(yīng) | Human, (predicted: Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, ) |
| 產(chǎn)品應(yīng)用 | ICC=1:50-200 IF=1:50-200
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 55kDa |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human Aromatase N-terminus |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 儲 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| 保存條件 | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. |
| 產(chǎn)品介紹 |
background: Aromatase is a key enzyme in steroidogenesis and plays an important role in sexual differentiation, oestrogen biosynthesis, fertility and carcinogenesis. It is highly conserved amongst mammals, and is highly expressed in placental tissue. Many environmental chemicals may influence aromatase activity and thereby disrupt endocrine function. Function: Catalyzes the formation of aromatic C18 estrogens from C19 androgens. Subcellular Location: Membrane; Peripheral membrane protein. Tissue Specificity: Brain, placenta and gonads. DISEASE: Aromatase excess syndrome (AEXS) [MIM:139300]: An autosomal dominant disorder characterized by increased extraglandular aromatization of steroids that presents with heterosexual precocity in males and isosexual precocity in females. Note=The disease is caused by mutations affecting the gene represented in this entry. Aromatase deficiency (AROD) [MIM:613546]: A rare disease in which fetal androgens are not converted into estrogens due to placental aromatase deficiency. Thus, pregnant women exhibit a hirsutism, which spontaneously resolves after post-partum. At birth, female babies present with pseudohermaphroditism due to virilization of extern genital organs. In adult females, manifestations include delay of puberty, breast hypoplasia and primary amenorrhoea with multicystic ovaries. Note=The disease is caused by mutations affecting the gene represented in this entry. Similarity: Belongs to the cytochrome P450 family. Database links: Entrez Gene: 1588 Human Entrez Gene: 13075 Mouse Omim: 107910 Human SwissProt: P19098 Chicken SwissProt: P11511 Human SwissProt: P28649 Mouse Unigene: 260074 Human Unigene: 478781 Mouse Unigene: 5199 Mouse Unigene: 21402 Rat Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 細胞色素氧化酶p450; 是一種微粒體酶系統(tǒng)，催化睪酮經(jīng)三步連續(xù)強化轉(zhuǎn)變成17-β-雌二醇,在反應(yīng)中睪酮作為激素原。 細胞色素P450主要分布在內(nèi)質(zhì)網(wǎng)和線粒體內(nèi)膜上，作為一種末端加氧酶，參與了生物體內(nèi)的甾醇類激素合成等過程。 近年來，對細胞色素P450的結(jié)構(gòu)、功能特別是對其在藥物代謝中的作用的研究有了較大的進展。 最新研究表明細胞色素P450還是藥物代謝過程中的關(guān)鍵酶，而且對細胞因子和體溫調(diào)節(jié)都有重要影響。 芳香化酶-細胞色素P450作為和藥物代謝及細胞因子相關(guān)的重要酶類，在藥物代謝和免疫中起著相當重要的作用，對于它的研究將有助于新藥的開發(fā)，并能幫助人們更加清楚的認識藥物的代謝途徑，在未來的新藥中減少副作用，增加藥物療效。隨著對細胞色素P450研究的深入，將有更多相關(guān)的藥物代謝途徑被發(fā)現(xiàn)，人們開發(fā)新藥的視野將更加開闊，新藥開發(fā)的速度也將加快，質(zhì)量進一步提高。 鑒于P450的研究無論在理論上探索生物的生理代謝、選擇進化和生物與環(huán)境的關(guān)系方面,或在環(huán)境保護、農(nóng)業(yè)生態(tài)、生物防治、作物基因工程和醫(yī)藥衛(wèi)生等應(yīng)用方面,都有廣泛的實踐意義,因此,應(yīng)該受到更大的關(guān)注和重視。 |
| 1、抗體溶解方法 | |
| 2、抗體修復(fù)方式 | |
| 3、常用試劑的配制 | |
| 4、免疫組化操作步驟 | |
| 5、免疫組化問題解答 | |
| 6、Western Blotting 操作步驟 | |
| 7、Western Blotting 問題解答 | |
| 8、關(guān)于肽鏈的設(shè)計 | |
| 9、多肽的溶解與保存 | |
| 10、酶標抗體效價測定程序 | |
